Copyright Reports & Markets. All rights reserved.

Global Transcriptome Technology Market Growth (Status and Outlook) 2023-2029

Request for Sample of this report
Buy now

1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered
  • 1.8 Market Estimation Caveats

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global Transcriptome Technology Market Size 2018-2029
    • 2.1.2 Transcriptome Technology Market Size CAGR by Region 2018 VS 2022 VS 2029
  • 2.2 Transcriptome Technology Segment by Type
    • 2.2.1 PCR
    • 2.2.2 Microarray
    • 2.2.3 Sequencing
  • 2.3 Transcriptome Technology Market Size by Type
    • 2.3.1 Transcriptome Technology Market Size CAGR by Type (2018 VS 2022 VS 2029)
    • 2.3.2 Global Transcriptome Technology Market Size Market Share by Type (2018-2023)
  • 2.4 Transcriptome Technology Segment by Application
    • 2.4.1 Pharmaceutical and Biotechnology
    • 2.4.2 Academic Research and Government Institutes
    • 2.4.3 Hospitals and Diagnostic Centers
  • 2.5 Transcriptome Technology Market Size by Application
    • 2.5.1 Transcriptome Technology Market Size CAGR by Application (2018 VS 2022 VS 2029)
    • 2.5.2 Global Transcriptome Technology Market Size Market Share by Application (2018-2023)

3 Transcriptome Technology Market Size by Player

  • 3.1 Transcriptome Technology Market Size Market Share by Players
    • 3.1.1 Global Transcriptome Technology Revenue by Players (2018-2023)
    • 3.1.2 Global Transcriptome Technology Revenue Market Share by Players (2018-2023)
  • 3.2 Global Transcriptome Technology Key Players Head office and Products Offered
  • 3.3 Market Concentration Rate Analysis
    • 3.3.1 Competition Landscape Analysis
    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
  • 3.4 New Products and Potential Entrants
  • 3.5 Mergers & Acquisitions, Expansion

4 Transcriptome Technology by Regions

  • 4.1 Transcriptome Technology Market Size by Regions (2018-2023)
  • 4.2 Americas Transcriptome Technology Market Size Growth (2018-2023)
  • 4.3 APAC Transcriptome Technology Market Size Growth (2018-2023)
  • 4.4 Europe Transcriptome Technology Market Size Growth (2018-2023)
  • 4.5 Middle East & Africa Transcriptome Technology Market Size Growth (2018-2023)

5 Americas

  • 5.1 Americas Transcriptome Technology Market Size by Country (2018-2023)
  • 5.2 Americas Transcriptome Technology Market Size by Type (2018-2023)
  • 5.3 Americas Transcriptome Technology Market Size by Application (2018-2023)
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC Transcriptome Technology Market Size by Region (2018-2023)
  • 6.2 APAC Transcriptome Technology Market Size by Type (2018-2023)
  • 6.3 APAC Transcriptome Technology Market Size by Application (2018-2023)
  • 6.4 China
  • 6.5 Japan
  • 6.6 Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia

7 Europe

  • 7.1 Europe Transcriptome Technology by Country (2018-2023)
  • 7.2 Europe Transcriptome Technology Market Size by Type (2018-2023)
  • 7.3 Europe Transcriptome Technology Market Size by Application (2018-2023)
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa Transcriptome Technology by Region (2018-2023)
  • 8.2 Middle East & Africa Transcriptome Technology Market Size by Type (2018-2023)
  • 8.3 Middle East & Africa Transcriptome Technology Market Size by Application (2018-2023)
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Global Transcriptome Technology Market Forecast

  • 10.1 Global Transcriptome Technology Forecast by Regions (2024-2029)
    • 10.1.1 Global Transcriptome Technology Forecast by Regions (2024-2029)
    • 10.1.2 Americas Transcriptome Technology Forecast
    • 10.1.3 APAC Transcriptome Technology Forecast
    • 10.1.4 Europe Transcriptome Technology Forecast
    • 10.1.5 Middle East & Africa Transcriptome Technology Forecast
  • 10.2 Americas Transcriptome Technology Forecast by Country (2024-2029)
    • 10.2.1 United States Transcriptome Technology Market Forecast
    • 10.2.2 Canada Transcriptome Technology Market Forecast
    • 10.2.3 Mexico Transcriptome Technology Market Forecast
    • 10.2.4 Brazil Transcriptome Technology Market Forecast
  • 10.3 APAC Transcriptome Technology Forecast by Region (2024-2029)
    • 10.3.1 China Transcriptome Technology Market Forecast
    • 10.3.2 Japan Transcriptome Technology Market Forecast
    • 10.3.3 Korea Transcriptome Technology Market Forecast
    • 10.3.4 Southeast Asia Transcriptome Technology Market Forecast
    • 10.3.5 India Transcriptome Technology Market Forecast
    • 10.3.6 Australia Transcriptome Technology Market Forecast
  • 10.4 Europe Transcriptome Technology Forecast by Country (2024-2029)
    • 10.4.1 Germany Transcriptome Technology Market Forecast
    • 10.4.2 France Transcriptome Technology Market Forecast
    • 10.4.3 UK Transcriptome Technology Market Forecast
    • 10.4.4 Italy Transcriptome Technology Market Forecast
    • 10.4.5 Russia Transcriptome Technology Market Forecast
  • 10.5 Middle East & Africa Transcriptome Technology Forecast by Region (2024-2029)
    • 10.5.1 Egypt Transcriptome Technology Market Forecast
    • 10.5.2 South Africa Transcriptome Technology Market Forecast
    • 10.5.3 Israel Transcriptome Technology Market Forecast
    • 10.5.4 Turkey Transcriptome Technology Market Forecast
    • 10.5.5 GCC Countries Transcriptome Technology Market Forecast
  • 10.6 Global Transcriptome Technology Forecast by Type (2024-2029)
  • 10.7 Global Transcriptome Technology Forecast by Application (2024-2029)

11 Key Players Analysis

  • 11.1 Thermo Fisher Scientific
    • 11.1.1 Thermo Fisher Scientific Company Information
    • 11.1.2 Thermo Fisher Scientific Transcriptome Technology Product Offered
    • 11.1.3 Thermo Fisher Scientific Transcriptome Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 11.1.4 Thermo Fisher Scientific Main Business Overview
    • 11.1.5 Thermo Fisher Scientific Latest Developments
  • 11.2 Illumina
    • 11.2.1 Illumina Company Information
    • 11.2.2 Illumina Transcriptome Technology Product Offered
    • 11.2.3 Illumina Transcriptome Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 11.2.4 Illumina Main Business Overview
    • 11.2.5 Illumina Latest Developments
  • 11.3 QIAGEN (Exiqon)
    • 11.3.1 QIAGEN (Exiqon) Company Information
    • 11.3.2 QIAGEN (Exiqon) Transcriptome Technology Product Offered
    • 11.3.3 QIAGEN (Exiqon) Transcriptome Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 11.3.4 QIAGEN (Exiqon) Main Business Overview
    • 11.3.5 QIAGEN (Exiqon) Latest Developments
  • 11.4 Agilent Technologies
    • 11.4.1 Agilent Technologies Company Information
    • 11.4.2 Agilent Technologies Transcriptome Technology Product Offered
    • 11.4.3 Agilent Technologies Transcriptome Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 11.4.4 Agilent Technologies Main Business Overview
    • 11.4.5 Agilent Technologies Latest Developments
  • 11.5 Roche
    • 11.5.1 Roche Company Information
    • 11.5.2 Roche Transcriptome Technology Product Offered
    • 11.5.3 Roche Transcriptome Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 11.5.4 Roche Main Business Overview
    • 11.5.5 Roche Latest Developments
  • 11.6 GE Healthcare
    • 11.6.1 GE Healthcare Company Information
    • 11.6.2 GE Healthcare Transcriptome Technology Product Offered
    • 11.6.3 GE Healthcare Transcriptome Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 11.6.4 GE Healthcare Main Business Overview
    • 11.6.5 GE Healthcare Latest Developments
  • 11.7 Bio-Rad Laboratories
    • 11.7.1 Bio-Rad Laboratories Company Information
    • 11.7.2 Bio-Rad Laboratories Transcriptome Technology Product Offered
    • 11.7.3 Bio-Rad Laboratories Transcriptome Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 11.7.4 Bio-Rad Laboratories Main Business Overview
    • 11.7.5 Bio-Rad Laboratories Latest Developments
  • 11.8 Fluidigm
    • 11.8.1 Fluidigm Company Information
    • 11.8.2 Fluidigm Transcriptome Technology Product Offered
    • 11.8.3 Fluidigm Transcriptome Technology Revenue, Gross Margin and Market Share (2018-2023)
    • 11.8.4 Fluidigm Main Business Overview
    • 11.8.5 Fluidigm Latest Developments

12 Research Findings and Conclusion

The global Transcriptome Technology market size is projected to grow from US$ 3438.5 million in 2022 to US$ 6861.7 million in 2029; it is expected to grow at a CAGR of 10.4% from 2023 to 2029.

United States market for Transcriptome Technology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Transcriptome Technology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Transcriptome Technology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Transcriptome Technology players cover Thermo Fisher Scientific, Illumina, QIAGEN (Exiqon), Agilent Technologies, Roche, GE Healthcare, Bio-Rad Laboratories and Fluidigm, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Transcriptomic incorporates the exploration and assortment of transcriptomes and finds diverse applications, chiefly in molecular genetics.

LPI (LP Information)' newest research report, the “Transcriptome Technology Industry Forecast” looks at past sales and reviews total world Transcriptome Technology sales in 2022, providing a comprehensive analysis by region and market sector of projected Transcriptome Technology sales for 2023 through 2029. With Transcriptome Technology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transcriptome Technology industry.

This Insight Report provides a comprehensive analysis of the global Transcriptome Technology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Transcriptome Technology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transcriptome Technology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transcriptome Technology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transcriptome Technology.

This report presents a comprehensive overview, market shares, and growth opportunities of Transcriptome Technology market by product type, application, key players and key regions and countries.

Market Segmentation:
Segmentation by type
PCR
Microarray
Sequencing

Segmentation by application
Pharmaceutical and Biotechnology
Academic Research and Government Institutes
Hospitals and Diagnostic Centers

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Illumina
QIAGEN (Exiqon)
Agilent Technologies
Roche
GE Healthcare
Bio-Rad Laboratories
Fluidigm

Buy now